Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Stryker Corporation before investing.

In this article, we go over a few key elements for understanding Stryker Corporation’s stock price such as:

• Stryker Corporation’s current stock price and volume
• Why Stryker Corporation’s stock price changed recently
• Upgrades and downgrades for SYK from analysts
• SYK’s stock price momentum as measured by its relative strength

About Stryker Corporation (SYK)

Before we jump into Stryker Corporation’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Want to learn more about Stryker Corporation’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Stryker Corporation.

Stryker Corporation’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, Stryker Corporation’s stock price was $325.700.

Stryker Corporation is down 6.42% from its previous closing price of $348.040.

During the last market session, Stryker Corporation’s stock traded between $317.615 and $334.460. Currently, there are approximately 382.90 million shares outstanding for Stryker Corporation.

Stryker Corporation’s price-earnings (P/E) ratio is currently at 40.3, which is high compared to the Health Care Equipment & Supplies industry median of 30.5. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Stryker Corporation Stock Price History

Stryker Corporation’s (SYK) price is currently up 3.45% so far this month.

During the month of July, Stryker Corporation’s stock price has reached a high of $352.490 and a low of $306.530.

Over the last year, Stryker Corporation has hit prices as high as $401.990 and as low as $281.000. Year to date, Stryker Corporation’s stock is down 7.33%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Stryker Corporation Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 30, 2026, there was 1 analyst who downgraded Stryker Corporation’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Stryker Corporation’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Stryker Corporation’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Stryker Corporation’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Stryker Corporation (SYK) by visiting AAII Stock Evaluator.

Relative Price Strength of Stryker Corporation

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 30, 2026, Stryker Corporation has a weighted four-quarter relative price strength of -4.01%, which translates to a Momentum Score of 38 and is considered to be Weak.

Want to learn more about how Stryker Corporation is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Stryker Corporation Stock Price: Bottom Line

As of July 31, 2026, Stryker Corporation’s stock price is $325.700, which is down 6.42% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Stryker Corporation stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.